Open Call MSCA-IF-2018: Individual Fellowships

European CommissionThe goal of the Individual Fellowships is to enhance the creative and innovative potential of experienced researchers, wishing to diversify their individual competence in terms of skill acquisition through advanced training, international and intersectoral mobility. Individual Fellowships provide opportunities to researchers of any nationality to acquire and transfer new knowledge and to work on research and innovation in Europe (EU Member States and Horizon 2020 Associated Countries) and beyond. The scheme particularly supports the return and (re)integration of European researchers from outside Europe and those who have previously worked here, as well as researchers displaced by conflict outside the EU and Horizon 2020 Associated Countries. It also promotes the career restart of individual researchers who show great potential.

Support is foreseen for individual, trans-national fellowships awarded to the best or most promising researchers of any nationality, for employment in EU Member States or Horizon 2020 Associated Countries. It is based on an application made jointly by the researcher and the beneficiary in the academic or non-academic sectors.

Only one proposal per individual researcher per call will be evaluated.

Fellowships take the form of European Fellowships or Global Fellowships. European Fellowships are held in EU Member States or Horizon 2020 Associated Countries and are open to researchers either coming to Europe from any country in the world or moving within Europe. The researcher must comply with the rules of mobility in the country where the European Fellowship is held.

Direct return to and long-term reintegration of researchers in Europe, including in their country of origin, is supported via a separate multi-disciplinary reintegration panel of the European Fellowships. For the reintegration panel, there must be direct mobility to the country of the beneficiary in Europe from a third country (compulsory national service and/or short stays such as holidays are not taken into account).

Support to individuals to resume research in Europe after a career break, e.g. after parental leave or due to recent migration, is ensured via a separate multi-disciplinary career restart panel of the European Fellowships. To qualify for the career restart panel, researchers must not have been active in research for a continuous period of at least 12 months within the 18 months immediately prior to the deadline for submission.

Researchers seeking to work on research and innovation projects in an organisation from the non-academic sector will be supported via a separate multi-disciplinary society and enterprise panel of the European Fellowships. The objective of this panel is to facilitate career moves between the academic and non-academic sectors, to stimulate innovation, and to open attractive career opportunities for researchers outside academia.

Deadline: 12 September 2018 17:00:00

Deadline Model: single-stage

Type of action:

  • MSCA-IF-GF Global Fellowships
  • MSCA-IF-EF-ST Standard European Fellowships
  • MSCA-IF-EF-SE Society and Enterprise panel
  • MSCA-IF-EF-RI Reintegration panel
  • MSCA-IF-EF-CAR Career Restart panel

For topic conditions, documents and submission service, please visit:
https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/msca-if-2018.html

PS: Find your partners or consortia preparing a project proposal
If you are working on Horizon 2020 research project proposals and you would be interested in a SME partner from Germany, please contact us, we are happy to share our experience, expertise and knowledge. If you need help to identify a potential partner with particular competences, facilities or experience, please join and explore our project, (HEALTH IT) SPACE, at www.healthitspace.eu.

Most Popular Now

Merck and Tencent Announce Collaboration…

Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading provider of Internet value added services. The collaboration will primarily focus on increasing public...

Merck Granted U.S. Patent for Novel Comb…

Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates...

The European Health Catapult Program for…

Through dedicated sessions, a group of international top-level investors, key healthcare leaders and industry stakeholders work closely together challenging 40+ ambitious startups to optimize their business plan and strengthen their...

Applications Now Open for Pioneering Dig…

The Yorkshire & Humber AHSN (Academic Health Science Network), in partnership with mHabitat, announces that applications for the 2019 Propel@YH digital health accelerator programme are now open. Propel@YH has been...

Flagship Axe the Fax Trust Rolls out Hyb…

Leeds Teaching Hospitals NHS Trust (LTHT), the organisation at the forefront of the national Axe the Fax campaign, is implementing an electronic fax solution to tackle its last remaining machines...

First EU Citizens Using ePrescriptions i…

The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country: Finnish patients are now able to go to a...

Boehringer Ingelheim (Canada) Ltd. and I…

Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology...

Final Report: Provision of a Market Stud…

The aim of the study is to examine the telemedicine market in Europe and to understand the factors that determine its development. The analysis maps telemedicine applications and solutions, and...

Open Access Drug Development Tools Featu…

New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new IMI2 Call for proposals launched today. The total budget of...

The NHS Long Term Plan: Cracking the Da …

Opinion Article by Prof. Michael Thick, Chief Medical Officer, Chief Clinical Information Officer, IMS MAXIMS Reading the NHS Long Term Plan this week, I had a definite sense of déjà vu...

Big Data Approach Shown to be Effective …

Researchers at Rensselaer Polytechnic Institute who developed a blood test to help diagnose autism spectrum disorder have now successfully applied their distinctive big data-based approach to evaluating possible treatments. The...

Highland Marketing Advisory Board Respon…

The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment...